5 drug pricing shifts to watch & Zepbound outperforms Novo GLP-1.

February 25, 2026

1. Drug pricing in 2026: 5 forces reshaping pharmacy economics Full story

2. Zepbound beats Novo Nordisk's experimental GLP-1 in head-to-head trial Full story

3. How SSM Health, City of Hope + others are bolstering the pharmacy workforce amid shortages: here.

 

4. Washington University to acquire St. Louis College of Pharmacy Full story

5. In State of the Union, Trump calls for Congress to codify most-favored-nation drug prices into law Full story

6. As specialty pharmacy grows, billing complexity is fueling denials. What leaders must address now here.

 

7. 16 pharmacy leaders on 2026 workforce crisis Full story

8. FDA OKs new pill for schizophrenia, bipolar disorder Full story

9. Cigna defeats GLP-1 disability bias lawsuit Full story

10. Henry Ford Health delivers Michigan's 1st hemophilia gene therapy Full story

11. 2 Connecticut cities accuse PBMs, drugmakers of 'insulin pricing scheme' Full story

 

12. 400+ rural hospitals at risk of closure. How Bon Secours Mercy, Sutter + others are protecting access here.

Becker's Learning Opportunities

13. Losing 1 physician can cost $1M. Find a roadmap to reduce turnover here.

14. What behavioral health leaders say is their No. 1 strategic priority in 2026: here.

15. 94% of healthcare leaders plan to increase AI spending. See what they’re prioritizing next here.

16. Interested in more? See Becker’s full lineup of webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ptwenter@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication